Cullinan Therapeutics (CGEM) Retained Earnings: 2020-2022
Historic Retained Earnings for Cullinan Therapeutics (CGEM) over the last 3 years, with Dec 2022 value amounting to -$47.7 million.
- Cullinan Therapeutics' Retained Earnings fell 746.62% to -$177.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$177.1 million, marking a year-over-year decrease of 746.62%. This contributed to the annual value of -$47.7 million for FY2022, which is 69.99% up from last year.
- As of FY2022, Cullinan Therapeutics' Retained Earnings stood at -$47.7 million, which was up 69.99% from -$158.9 million recorded in FY2021.
- Over the past 5 years, Cullinan Therapeutics' Retained Earnings peaked at -$47.7 million during FY2022, and registered a low of -$158.9 million during FY2021.
- In the last 3 years, Cullinan Therapeutics' Retained Earnings had a median value of -$93.3 million in 2020 and averaged -$100.0 million.
- In the last 5 years, Cullinan Therapeutics' Retained Earnings crashed by 70.25% in 2021 and then soared by 69.99% in 2022.
- Over the past 3 years, Cullinan Therapeutics' Retained Earnings (Yearly) stood at -$93.3 million in 2020, then plummeted by 70.25% to -$158.9 million in 2021, then skyrocketed by 69.99% to -$47.7 million in 2022.